Oral valproic acid fails to benefit patients with retinitis pigmentosa
- Posted on: Sep 26 2018
- Leave a response
This paper reports results from a phase 2 trial evaluating oral valproic acid for treating autosomal dominant retinitis pigmentosa.
Source: AAO
Posted in: Uncategorized
